Quarterly
Annual
| Unit: USD | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
non-current assets | |||
property, plant and equipment | 512,000,000 | 492,000,000 | 441,000,000 |
intangible assets and goodwill | 916,000,000 | 904,000,000 | 675,000,000 |
associates and joint venture | 102,000,000 | 107,000,000 | 14,000,000 |
deferred tax assets | 56,000,000 | 20,000,000 | 5,000,000 |
other investments | 1,188,000,000 | 1,742,000,000 | 1,241,000,000 |
loan receivables in the financial services segment | 54,000,000 | ||
deposits, prepayments and other assets | 196,000,000 | ||
current assets | |||
inventories | 49,000,000 | 48,000,000 | 4,000,000 |
trade and other receivables | 196,000,000 | 372,000,000 | 255,000,000 |
cash and cash equivalents | 3,138,000,000 | 1,952,000,000 | 4,991,000,000 |
total assets | 8,792,000,000 | 9,170,000,000 | 11,178,000,000 |
equity | |||
share capital and share premium | 22,669,000,000 | 22,278,000,000 | 21,529,000,000 |
reserves | 544,000,000 | 602,000,000 | 606,000,000 |
accumulated losses | -16,764,000,000 | -16,277,000,000 | -14,402,000,000 |
equity attributable to owners of the company | 6,449,000,000 | 6,603,000,000 | |
non-controlling interests | 19,000,000 | 54,000,000 | 286,000,000 |
total equity | 6,468,000,000 | 6,657,000,000 | |
non-current liabilities | |||
loans and borrowings | 668,000,000 | 1,248,000,000 | 2,031,000,000 |
provisions | 18,000,000 | 18,000,000 | 18,000,000 |
other liabilities | 140,000,000 | 132,000,000 | |
deferred tax liabilities | 20,000,000 | 18,000,000 | 3,000,000 |
current liabilities | |||
trade payables and other liabilities | 925,000,000 | 933,000,000 | |
deposits from customers in the banking business | 374,000,000 | ||
current tax liabilities | 15,000,000 | 9,000,000 | 3,000,000 |
total liabilities | 2,324,000,000 | 2,513,000,000 | 3,159,000,000 |
total equity and liabilities | 8,792,000,000 | 9,170,000,000 | |
revenue | |||
cost of revenue | |||
other income | |||
sales and marketing expenses | |||
general and administrative expenses | |||
research and development expenses | |||
net impairment losses on financial assets | |||
other incomes* | |||
restructuring costs | |||
operating income | |||
finance income | |||
finance costs | |||
net change in fair value of financial assets and liabilities | |||
share listing and associated expenses | |||
net finance income/ | |||
share of loss of equity-accounted investees | |||
income before income tax | |||
income tax expense | |||
loss for the year | |||
items that will not be reclassified to profit or loss: | |||
defined benefit plan remeasurements | |||
investments and put liabilities at fvoci – net change in fair value | |||
items that are or may be reclassified subsequently to profit or loss: | |||
foreign currency translation differences – foreign operations | |||
other comprehensive loss for the year, net of tax | |||
total comprehensive loss for the year | |||
loss attributable to: | |||
owners of the company | |||
total comprehensive loss attributable to: | |||
loss per share | |||
basic loss per share | |||
diluted loss per share | |||
prepayments and other assets | 217,000,000 | 127,000,000 | |
other incomes | |||
net finance costs | |||
other comprehensive (loss)/ income for the year, net of tax | |||
equity/(deficit) attributable to owners of the company | 7,733,000,000 | ||
total equity/ | 8,019,000,000 | ||
convertible redeemable preference shares | |||
warrant liabilities | 54,000,000 | ||
trade and other payables | 27,000,000 | ||
total equity/(deficit) and liabilities | 11,178,000,000 | ||
* |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.